Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Moodys
Boehringer Ingelheim
Johnson and Johnson
Baxter

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Zoliflodacin

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Zoliflodacin?

Zoliflodacin is an investigational drug.

There have been 4 clinical trials for Zoliflodacin. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2019.

The most common disease conditions in clinical trials are Gonorrhea and [disabled in preview]. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Drugs for Neglected Diseases, and Quotient Sciences.

There are five US patents protecting this investigational drug and thirty-seven international patents.

Recent Clinical Trials for Zoliflodacin
TitleSponsorPhase
Zoliflodacin in Uncomplicated GonorrhoeaGlobal Antibiotics Research and Development PartnershipPhase 3
Study to Investigate Effect of Food and Safety of a New Formulation of ZoliflodacinQuotient SciencesPhase 1
Study to Investigate Effect of Food and Safety of a New Formulation of ZoliflodacinDrugs for Neglected DiseasesPhase 1

See all Zoliflodacin clinical trials

Clinical Trial Summary for Zoliflodacin

Top disease conditions for Zoliflodacin
Top clinical trial sponsors for Zoliflodacin

See all Zoliflodacin clinical trials

US Patents for Zoliflodacin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Zoliflodacin   Start Trial Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections Entasis Therapeutics Limited (London, GB)   Start Trial
Zoliflodacin   Start Trial Compounds and methods for treating bacterial infections AstraZeneca AB (Sodertalje, SE)   Start Trial
Zoliflodacin   Start Trial Compounds and methods for treating bacterial infections Entasis Therapeutics Limited (London, GB)   Start Trial
Zoliflodacin   Start Trial Compounds and methods for treating bacterial infections Entasis Therapeutics Limited (London, GB)   Start Trial
Zoliflodacin   Start Trial Compounds and methods for treating bacterial infections Entasis Therapeutics Limited (London, GB)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Zoliflodacin

Drugname Country Document Number Estimated Expiration Related US Patent
Zoliflodacin Australia 2015265620 2034-05-29   Start Trial
Zoliflodacin Canada 2948438 2034-05-29   Start Trial
Zoliflodacin China 106659725 2034-05-29   Start Trial
Zoliflodacin Eurasian Patent Organization 201692250 2034-05-29   Start Trial
Zoliflodacin European Patent Office 3148546 2034-05-29   Start Trial
Zoliflodacin Israel 248838 2034-05-29   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Mallinckrodt
AstraZeneca
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.